Chicago-based AbbVie announced plans for a strategic collaboration with the Cystic Fibrosis Foundation. AbbVie will work to develop a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator compound that it licensed from the Foundation.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,